{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:16:08Z","timestamp":1791728168559,"version":"4.3.4"},"reference-count":81,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017490","name":"Arla Foods Ingredients Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017490","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010887","name":"Vitaflo International Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010887","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ymgme.2024.108607","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T17:13:53Z","timestamp":1730740433000},"page":"108607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The effects of casein glycomacropeptide on general health status in children with PKU: A randomized crossover trial"],"prefix":"10.1016","volume":"143","author":[{"given":"Alex","family":"Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Robotham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Heales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Aitkenhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ashmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falio Cesar","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Ilgaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Hickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9750","key":"10.1016\/j.ymgme.2024.108607_bb0005","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","article-title":"Phenylketonuria","volume":"376","author":"Blau","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41572-021-00267-0","article-title":"Phenylketonuria","volume":"7","author":"van Spronsen","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jnr.24598","article-title":"White matter disturbances in phenylketonuria: possible underlying mechanisms","volume":"99","author":"Ferreira","year":"2021","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108607_bb0020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/jcbfm.2014.183","article-title":"Phenylketonuria: brain phenylalanine concentrations relate inversely to cerebral protein synthesis","volume":"35","author":"de Groot","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108607_bb0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ymgme.2008.12.019","article-title":"Phenylketonuria: high plasma phenylalanine decreases cerebral protein synthesis","volume":"96","author":"Hoeksma","year":"2009","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108464","article-title":"Does hyperphenylalaninemia induce brain glucose hypometabolism? Cerebral spinal fluid findings in treated adult phenylketonuric patients","volume":"142","author":"Trefz","year":"2024","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108607_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107684","article-title":"Metabolic control and clinical outcome in adolescents with phenylketonuria","volume":"140","author":"De Giorgi","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108607_bb0040","author":"BIOPKU"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13023-020-01391-y","article-title":"PKU dietary handbook to accompany PKU guidelines","volume":"15","author":"MacDonald","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108607_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020484","article-title":"Protein substitutes in PKU; their historical evolution","volume":"13","author":"Daly","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","article-title":"The complete European guidelines on phenylketonuria: diagnosis and treatment","volume":"12","author":"van Wegberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2024.108607_bb0060","article-title":"Nutrient intake, body composition, and blood phenylalanine control in children with phenylketonuria compared to healthy controls","volume":"23","author":"Sailer","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0065","first-page":"31","article-title":"Casein glycomacropeptide in phenylketonuria: does it bring clinical benefit?","volume":"27","author":"Daly","year":"2024","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13594-012-0095-0","article-title":"Chemical and functional properties of glycomacropeptide (GMP) and its role in the detection of cheese whey adulteration in milk: a review","volume":"93","author":"Neelima","year":"2013","journal-title":"Dairy Sci. Technol."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108607_bb0075","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/glycob\/cwt162","article-title":"Structural and functional characteristics of bovine milk protein glycosylation","volume":"24","author":"O\u2019Riordan","year":"2014","journal-title":"Glycobiology"},{"issue":"10","key":"10.1016\/j.ymgme.2024.108607_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/foods7100166","article-title":"Fractionation of Glycomacropeptide from whey using positively charged ultrafiltration membranes","volume":"7","author":"Arunkumar","year":"2018","journal-title":"Foods"},{"key":"10.1016\/j.ymgme.2024.108607_bb0085","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0006-291X(65)90145-2","article-title":"Caseino-Glycopeptides: characterization of a methionine residue and of the n-terminal sequence","volume":"19","author":"Delfour","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10545-008-0952-4","article-title":"Nutritional management of PKU with glycomacropeptide from cheese whey","volume":"32","author":"Ney","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108607_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/nu14091883","article-title":"Glycomacropeptide safety and its effect on gut microbiota in patients with phenylketonuria: a pilot study","volume":"14","author":"Montanari","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2024.108607_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2021.104442","article-title":"Milk-derived anti-infectives and their potential to combat bacterial and viral infection","volume":"81","author":"Morrin","year":"2021","journal-title":"J. Funct. Foods"},{"issue":"18","key":"10.1016\/j.ymgme.2024.108607_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/nu15183991","article-title":"The role of bovine kappa-casein Glycomacropeptide in modulating the microbiome and inflammatory responses of irritable bowel syndrome","volume":"15","author":"Qu","year":"2023","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108607_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5005\/jcdp-10-3-1","article-title":"Anticariogenicity of casein phosphopeptide-amorphous calcium phosphate: a review of the literature","volume":"10","author":"Llena","year":"2009","journal-title":"J. Contemp. Dent. Pract."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108607_bb0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5851\/kosfa.2024.e12","article-title":"Potential prebiotic properties of whey protein and Glycomacropeptide in gut microbiome","volume":"44","author":"Rackerby","year":"2024","journal-title":"Food Sci. Anim. Resour."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108607_bb0120","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3390\/foods12071528","article-title":"Protective effect of Glycomacropeptide on the inflammatory response of U937 macrophages","volume":"12","author":"C\u00f3rdova-D\u00e1valos","year":"2023","journal-title":"Foods"},{"key":"10.1016\/j.ymgme.2024.108607_bb0125","series-title":"Glycomacropeptide: Biological Activities and Uses","first-page":"3","author":"Juan","year":"2018"},{"issue":"5","key":"10.1016\/j.ymgme.2024.108607_bb0130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.sjbs.2015.06.005","article-title":"Milk derived bioactive peptides and their impact on human health - a review","volume":"23","author":"Mohanty","year":"2016","journal-title":"Saudi J. Biol. Sci."},{"issue":"23","key":"10.1016\/j.ymgme.2024.108607_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/nu15234942","article-title":"Macrophage-immunomodulatory actions of bovine whey protein isolate, glycomacropeptide, and their in vitro and in vivo digests","volume":"15","author":"Olsen","year":"2023","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.ymgme.2024.108607_bb0140","doi-asserted-by":"crossref","first-page":"E885","DOI":"10.1152\/ajpendo.00647.2011","article-title":"Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria","volume":"302","author":"Solverson","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108607_bb0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jfca.2009.12.004","article-title":"Quantitation of N-acetylneuraminic (sialic) acid in bovine glycomacropeptide (GMP)","volume":"23","author":"Fernando","year":"2010","journal-title":"J. Food Compos. Anal."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108607_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/nu13062075","article-title":"A three-year longitudinal study comparing bone mass, density, and geometry measured by DXA, pQCT, and bone turnover markers in children with PKU taking L-amino acid or Glycomacropeptide protein substitutes","volume":"13","author":"Daly","year":"2021","journal-title":"Nutrients"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2024.108607_bb0155","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ymgme.2007.06.004","article-title":"Acceptable low-phenylalanine foods and beverages can be made with glycomacropeptide from cheese whey for individuals with PKU","volume":"92","author":"Lim","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108607_bb0160","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3945\/ajcn.2008.27280","article-title":"Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids","volume":"89","author":"van Calcar","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0165","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/ab4097","article-title":"Investigation of paediatric PKU breath malodour, comparing glycomacropeptide with phenylalanine free L-amino acid supplements","volume":"14","author":"Tiele","year":"2019","journal-title":"J. Breath Res."},{"issue":"Pt 1","key":"10.1016\/j.ymgme.2024.108607_bb0170","article-title":"Glycomacropeptide (GMP) rescued the oxidative and inflammatory activity of free L-AAs in human Caco-2 cells: new insights that support GMP as a valid and health-promoting product for the dietary management of phenylketonuria (PKU) patients","volume":"173","author":"Lammi","year":"2023","journal-title":"Food Res. Int."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108607_bb0175","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11136-014-0781-x","article-title":"PedsQL\u2122 gastrointestinal symptoms scales and gastrointestinal worry scales in pediatric patients with functional and organic gastrointestinal diseases in comparison to healthy controls","volume":"24","author":"Varni","year":"2015","journal-title":"Qual. Life Res."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108607_bb0180","doi-asserted-by":"crossref","first-page":"F219","DOI":"10.1136\/adc.2010.205864","article-title":"Designing the new UK-WHO growth charts to enhance assessment of growth around birth","volume":"97","author":"Cole","year":"2012","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"10.1016\/j.ymgme.2024.108607_bb0185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.appet.2014.03.011","article-title":"Measuring hunger and satiety in primary school children. Validation of a new picture rating scale","volume":"78","author":"Bennett","year":"2014","journal-title":"Appetite"},{"issue":"9","key":"10.1016\/j.ymgme.2024.108607_bb0190","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108607_bb0195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3945\/ajcn.116.135293","article-title":"Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial","volume":"104","author":"Ney","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108607_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093224","article-title":"Casein Glycomacropeptide: an alternative protein substitute in Tyrosinemia type I","volume":"13","author":"Daly","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108607_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030529","article-title":"How does feeding development and progression onto solid foods in PKU compare with non-PKU children during weaning?","volume":"11","author":"Evans","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2024.108607_bb0210","first-page":"57","article-title":"Living with phenylketonuria: lessons from the PKU community","volume":"17","author":"Ford","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2024.108607_bb0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1651-2227.1994.tb13457.x","article-title":"Feeding problems in young PKU children","volume":"407","author":"MacDonald","year":"1994","journal-title":"Acta Paediatr. Suppl."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.108120","article-title":"Management of phenylketonuria in European PKU centres remains heterogeneous","volume":"141","author":"Ahring","year":"2024","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108607_bb0225","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2018.09.006","article-title":"Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria","volume":"125","author":"Burton","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108607_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2020.109240","article-title":"Transport, metabolism and remedial potential of functional food extracts (FFEs) in Caco-2 cells monolayer: a review","volume":"136","author":"Iftikhar","year":"2020","journal-title":"Food Res. Int."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108607_bb0235","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.earlhumdev.2014.06.005","article-title":"Comparison of the different kinds of feeding on the level of fecal calprotectin","volume":"90","author":"Li","year":"2014","journal-title":"Early Hum. Dev."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108607_bb0240","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.3390\/nu12113319","article-title":"Nutrition, microbiota and role of gut-brain Axis in subjects with phenylketonuria (PKU): a review","volume":"12","author":"Verduci","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108607_bb0245","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ymgme.2017.04.003","article-title":"Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuria","volume":"121","author":"Ney","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108607_bb0250","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ymgme.2010.04.003","article-title":"Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria","volume":"100","author":"MacLeod","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0255","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13023-021-01721-8","article-title":"Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective","volume":"16","author":"Pena","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108607_bb0260","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ejcn.2017.38","article-title":"Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source","volume":"71","author":"Pinto","year":"2017","journal-title":"Eur. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0265","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00125-015-3751-0","article-title":"Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis","volume":"59","author":"Abdulla","year":"2016","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.ymgme.2024.108607_bb0270","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11357-015-9825-6","article-title":"Serum albumin and muscle measures in a cohort of healthy young and old participants","volume":"37","author":"Reijnierse","year":"2015","journal-title":"Age (Dordr.)"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108607_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/nu13041323","article-title":"Growth and body composition in PKU children-a three-year prospective study comparing the effects of L-amino acid to Glycomacropeptide protein substitutes","volume":"13","author":"Daly","year":"2021","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.ymgme.2024.108607_bb0280","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/eci.12634","article-title":"Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study","volume":"46","author":"Hvas","year":"2016","journal-title":"Eur. J. Clin. Invest."},{"issue":"Pt B","key":"10.1016\/j.ymgme.2024.108607_bb0285","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijdevneu.2015.10.001","article-title":"Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients","volume":"47","author":"Deon","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108607_bb0290","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ymgme.2012.10.006","article-title":"Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome","volume":"107","author":"Rocha","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108607_bb0295","first-page":"446","article-title":"No evidence for systemic low-grade inflammation in adult patients with early-treated phenylketonuria: the INGRAPH study","volume":"64","author":"Giret","year":"2023","journal-title":"JIMD Rep."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108607_bb0300","doi-asserted-by":"crossref","first-page":"G590","DOI":"10.1152\/ajpgi.00211.2015","article-title":"Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice","volume":"309","author":"Sawin","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108607_bb0305","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/j.2040-4603.2018.tb00036.x","article-title":"Adiponectin regulation and function","volume":"8","author":"Fang","year":"2018","journal-title":"Compr. Physiol."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0310","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1038\/s41467-021-22107-1","article-title":"The Pah-R261Q mouse reveals oxidative stress associated with amyloid-like hepatic aggregation of mutant phenylalanine hydroxylase","volume":"12","author":"Aubi","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108607_bb0315","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/antiox12030651","article-title":"Aging hallmarks and the role of oxidative stress","volume":"12","author":"Maldonado","year":"2023","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108607_bb0320","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijdevneu.2009.01.001","article-title":"Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients","volume":"27","author":"Sitta","year":"2009","journal-title":"Int. J. Dev. Neurosci."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108607_bb0325","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s10571-017-0573-2","article-title":"Effect of blood phenylalanine levels on oxidative stress in classical Phenylketonuric patients","volume":"38","author":"Kumru","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108607_bb0330","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ymgme.2022.03.012","article-title":"Phenylketonuria oxidative stress and energy dysregulation: emerging pathophysiological elements provide interventional opportunity","volume":"136","author":"Dobrowolski","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108607_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/nu16060871","article-title":"Glycomacropeptide as an efficient agent to fight pathophysiological mechanisms of metabolic syndrome","volume":"16","author":"Sauv\u00e9","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0340","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13023-019-1153-y","article-title":"Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data","volume":"14","author":"Trefz","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"20","key":"10.1016\/j.ymgme.2024.108607_bb0345","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14251","article-title":"Sex effects of dietary protein source and acid load on renal and bone status in the Pah(enu2) mouse model of phenylketonuria","volume":"7","author":"Stroup","year":"2019","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.ymgme.2024.108607_bb0350","doi-asserted-by":"crossref","first-page":"1909101","DOI":"10.1155\/2017\/1909101","article-title":"Amino acid medical foods provide a high dietary acid load and increase urinary excretion of renal net acid, calcium, and magnesium compared with Glycomacropeptide medical foods in phenylketonuria","volume":"2017","author":"Stroup","year":"2017","journal-title":"J. Nutr. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108607_bb0355","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000531913","article-title":"Long-term renal function in adult patients with phenylketonuria","volume":"148","author":"Prepok","year":"2024","journal-title":"Nephron"},{"issue":"5","key":"10.1016\/j.ymgme.2024.108607_bb0360","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10545-012-9548-0","article-title":"Chronic kidney disease in adolescent and adult patients with phenylketonuria","volume":"36","author":"Hennermann","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108607_bb0365","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.physbeh.2008.01.003","article-title":"Protein-induced satiety: effects and mechanisms of different proteins","volume":"94","author":"Veldhorst","year":"2008","journal-title":"Physiol. Behav."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108607_bb0370","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.3168\/jds.2023-24152","article-title":"A dairy-based, protein-rich breakfast enhances satiety and cognitive concentration before lunch in overweight to obese young females: a randomized controlled crossover study","volume":"107","author":"Dalgaard","year":"2024","journal-title":"J. Dairy Sci."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108607_bb0375","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3945\/an.113.003723","article-title":"Effect of dairy proteins on appetite, energy expenditure, body weight, and composition: a review of the evidence from controlled clinical trials","volume":"4","author":"Bendtsen","year":"2013","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.ymgme.2024.108607_bb0380","doi-asserted-by":"crossref","first-page":"6352919","DOI":"10.1155\/2018\/6352919","article-title":"Comparison of Glycomacropeptide with phenylalanine free-synthetic amino acids in test meals to PKU patients: no significant differences in biomarkers, including plasma Phe levels","volume":"2018","author":"Ahring","year":"2018","journal-title":"J. Nutr. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108607_bb0385","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jhn.12346","article-title":"Food acceptance and neophobia in children with phenylketonuria: a prospective controlled study","volume":"29","author":"Evans","year":"2016","journal-title":"J. Hum. Nutr. Diet."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108607_bb0390","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10545-010-9073-y","article-title":"The reality of dietary compliance in the management of phenylketonuria","volume":"33","author":"MacDonald","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108607_bb0395","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13023-019-1011-y","article-title":"Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU","volume":"14","author":"Daly","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2024.108607_bb0400","article-title":"A retrospective analysis of metabolic control in children with PKU in the COVID-19 era","volume":"32","author":"Becsei","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2024.108607_bb0405","article-title":"PKU and COVID19: how the pandemic changed metabolic control","volume":"27","author":"Rovelli","year":"2021","journal-title":"Mol. Genet. Metab. Rep."}],"updated-by":[{"DOI":"10.1016\/j.ymgme.2025.109077","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000}}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:45:08Z","timestamp":1762364708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719224004918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1096719224004918"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108607","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of casein glycomacropeptide on general health status in children with PKU: A randomized crossover trial","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108607"}}